1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,426 | 0,456 | 13:10 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.10. | OrbusNeich Medical Group Holdings Limited: OrbusNeich Expands European Footprint via Acquisition of Italian Distributor | 825 | JCN Newswire | - Strategic Deal Strengthens Direct Sales Capabilities and Supports Continued Growth Across EuropeHONG KONG, Oct 20, 2026 - (ACN Newswire) - OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or... ► Artikel lesen | |
| 20.10. | ORBUSNEICH Completes Acquisition of Entire Equity Interest in Italian Distributor | 2 | AASTOCKS | ||
| 20.10. | ORBUSNEICH (06929): VOLUNTARY ANNOUNCEMENT - ACQUISITION OF ITALIAN DISTRIBUTOR | 2 | HKEx | ||
| 18.09. | Dividendenbekanntmachungen (18.09.2026) | 7.415 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABSA GROUP LIMITED ADR US00400T1025 1,0607 USD 0,9241 EUR BANK7 CORP US06652N1072 0,3 USD 0,2613 EUR CHU KONG SHIPPING ENTERPRISES... ► Artikel lesen | |
| ORBUSNEICH MEDICAL GROUP Aktie jetzt für 0€ handeln | |||||
| 07.09. | ORBUSNEICH (06929): INTERIM REPORT 2026 | 1 | HKEx | ||
| 17.08. | ORBUSNEICH (06929): CHANGE OF OFFICERS AND COMPANY SECRETARY | 1 | HKEx | ||
| 14.08. | ORBUSNEICH (06929): DECLARATION OF INTERIM DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS (UPDATED) | 1 | HKEx | ||
| 13.08. | OrbusNeich Medical Group Holdings Limited: OrbusNeich Reports Growth Across All Geographies in 2026 Interim Results | 2.803 | JCN Newswire | - Revenue Up 18.1% to US$98.7 Million- Net Profit Rises to US$21.6 Million- Declares First Interim Dividend of HK8 Cents Per ShareHONG KONG, Aug 13, 2026 - (ACN Newswire) - Results Highlights:- Revenue... ► Artikel lesen | |
| 13.08. | OrbusNeich Medical Group Holdings Limited H1 Profit Climbs | 5 | RTTNews | ||
| 13.08. | ORBUSNEICH (06929): DECLARATION OF INTERIM DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS | 6 | HKEx | ||
| 13.08. | ORBUSNEICH (06929): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2026 | 2 | HKEx | ||
| 31.07. | ORBUSNEICH (06929): DATE OF BOARD MEETING | 1 | HKEx | ||
| 24.07. | OrbusNeich Medical Group Holdings Limited: OrbusNeich Announces Enrollment of First Patient in Japan Clinical Trial for its Proprietary Drug-Coated Balloon | 821 | JCN Newswire | HONG KONG, July 22, 2026 - (ACN Newswire) - OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group' stock code: 6929), a multinational medical device company specializing in interventional... ► Artikel lesen | |
| 22.07. | ORBUSNEICH (06929): VOLUNTARY ANNOUNCEMENT - FIRST PATIENT ENROLLMENT IN JAPAN CLINICAL TRIAL FOR ITS PROPRIETARY DRUG-COATED BALLOON | 1 | HKEx | ||
| 09.06. | XFRA CAPITAL ADJUSTMENT INFORMATION - 09.06.2026 | 1.067 | Xetra Newsboard | Das Instrument G85 CA35958L1013 FUERTE METALS CORP. EQUITY wird cum Kapitalmassnahme gehandelt am 09.06.2026 und ex Kapitalmassnahme am 10.06.2026 The instrument G85 CA35958L1013 FUERTE METALS CORP.... ► Artikel lesen | |
| 08.06. | ORBUSNEICH (06929): (1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 8, 2026 AND (2) PAYMENT OF FINAL DIVIDEND | 1 | HKEx | ||
| 12.03. | OrbusNeich Medical Group Holdings Limited: OrbusNeich Achieves Record-breaking Revenue, Sales Volume and Gross Profit in FY2025, Net Profit Rises to US$42 million, Final Dividend Increases by 20% to HK12 Cents per Share | 882 | JCN Newswire | - Sharpens Competitive Edge in Commercialization and Product Innovation- While Exploring New Business Models for Sustainable GrowthHONG KONG, Mar 12, 2026 - (ACN Newswire) - Results Highlights:- Revenue... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEARTFLOW | 57,82 | 0,00 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,100 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 58,38 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| NUWELLIS, INC | 5,370 | 0,00 % | Nuwellis: Interview With President And CEO Mike McCormick About Precision Fluid Management And Cardiorenal Care | ||
| SIEMENS HEALTHINEERS | 42,040 | +0,41 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,055 | 0,00 % | Needham initiates Alignment Healthcare stock rating at Hold | ||
| GENEDX | 62,63 | 0,00 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| BILLIONTOONE | 114,02 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| BETA BIONICS | 21,440 | +0,23 % | Truist reiterates Buy on Beta Bionics stock, $28 target on MINT | ||
| PROGYNY | 27,720 | 0,00 % | Progyny, Inc.: New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model | ||
| FRESENIUS | 46,005 | -0,54 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat Fresenius auf "Buy" mit einem Kursziel von 55 Euro belassen. Die Gewinndynamik des Medizinkonzerns sollte sich im dritten Quartal fortgesetzt... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 29,960 | 0,00 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results | KIRKLAND, Wash., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,700 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,260 | -0,76 % | DZ BANK stuft FMC FRESENIUS MEDICAL CARE AG auf 'Kaufen' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für FMC von 54 auf 46 Euro gesenk, aber die Einstufung auf "Kaufen" belassen. Dass die US-Regierung die Behandlung von Nierenerkrankungen... ► Artikel lesen |
Das Unternehmen ORBUSNEICH MEDICAL GROUP HOLDINGS LTD kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,004 (+1,09 %) liegt der Kurs bei 0,370 Euro. Aus der Ausschüttung der letzten 12 Monate von insgesamt 0,00 Euro errechnet sich eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ORBUSNEICH MEDICAL GROUP HOLDINGS LTD finden Sie auf Wallstreet Online.